Recent advances in lean NAFLD

Immunology and Microbiology

• All Cause Mortality 50%
• Epigenetic Modification 50%
• Epigenetics 50%
• Genetic Susceptibility 50%
• Prevalence 100%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 9%
• Chronic Liver Disease 9%
• Fibrosis 9%
• Genetic Susceptibility 9%
• Hypertriglyceridemia 9%
• Metabolic Syndrome X 9%
• Nonalcoholic Fatty Liver 100%
• Obesity 9%
• Prevalence 18%

Keyphrases

• Lean Nonalcoholic Fatty Liver Disease 100%
• Lean Patients 16%